ArticleBlood research2023

Concomitant ruxolitinib with cytarabine-based induction chemotherapy in secondary acute myeloid leukemia evolving from myeloproliferative neoplasm.

Dong Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.